Table 2.
A comparison of individual HPV genotypes detected in paired aliquots, treated (T) and untreated (U), of specimens from 100 women with LSIL cytology. The results were then stratified on the time of alkalinization (treatment), 10 hours (n = 50) or 18 hours (n = 50). Bold type indicates statistical significant greater (P < 0.05, McNemar’s χ2 test) detection in one aliquot versus the other.
| All | 10h Alkalinization | 18h Alkalinization | ||||
|---|---|---|---|---|---|---|
| N = 100 | N = 50 | N = 50 | ||||
| T | U | T | U | T | U | |
| Any HPV | 96% | 97% | 96% | 100% | 96% | 94% |
| Any Carcinogenic HPV | 86% | 87% | 88% | 92% | 84% | 82% |
| HPV6 | 12% | 14% | 10% | 14% | 14% | 14% |
| HPV11 | 2% | 1% | 2% | 0% | 2% | 2% |
| HPV16 | 21% | 28% | 26% | 38% | 16% | 18% |
| HPV18 | 8% | 11% | 10% | 18% | 6% | 4% |
| HPV26 | 0% | 0% | 0% | 0% | 0% | 0% |
| HPV31 | 8% | 8% | 6% | 4% | 10% | 12% |
| HPV33 | 3% | 2% | 2% | 2% | 4% | 2% |
| HPV35 | 7% | 8% | 8% | 8% | 6% | 8% |
| HPV39 | 21% | 19% | 8% | 14% | 34% | 24% |
| HPV40 | 3% | 5% | 2% | 6% | 4% | 4% |
| HPV42 | 3% | 5% | 2% | 8% | 4% | 2% |
| HPV45 | 10% | 4% | 6% | 6% | 14% | 2% |
| HPV51 | 26% | 23% | 26% | 28% | 26% | 18% |
| HPV52† | 23% | 23% | 20% | 24% | 26% | 22% |
| HPV53 | 17% | 16% | 18% | 16% | 16% | 16% |
| HPV54 | 0% | 0% | 0% | 0% | 0% | 0% |
| HPV55 | 3% | 4% | 2% | 4% | 4% | 4% |
| HPV56 | 9% | 9% | 8% | 8% | 10% | 10% |
| HPV58 | 4% | 5% | 0% | 2% | 8% | 8% |
| HPV59 | 13% | 8% | 2% | 0% | 24% | 16% |
| HPV61 | 6% | 2% | 0% | 0% | 12% | 4% |
| HPV62 | 7% | 7% | 2% | 4% | 12% | 10% |
| HPV64 | 0% | 0% | 0% | 0% | 0% | 0% |
| HPV66 | 22% | 24% | 18% | 24% | 26% | 24% |
| HPV67 | 3% | 4% | 2% | 4% | 4% | 4% |
| HPV68 | 6% | 8% | 8% | 14% | 4% | 2% |
| HPV69 | 0% | 0% | 0% | 0% | 0% | 0% |
| HPV70 | 3% | 3% | 0% | 2% | 6% | 4% |
| HPV71 | 0% | 0% | 0% | 0% | 0% | 0% |
| HPV72 | 0% | 0% | 0% | 0% | 0% | 0% |
| HPV73 | 1% | 2% | 0% | 2% | 2% | 2% |
| HPV81 | 3% | 3% | 2% | 0% | 4% | 6% |
| HPV82 | 8% | 6% | 4% | 4% | 12% | 8% |
| HPV82v | 10% | 10% | 10% | 14% | 10% | 6% |
| HPV83 | 2% | 1% | 2% | 0% | 2% | 2% |
| HPV84 | 11% | 11% | 10% | 12% | 12% | 10% |
| HPV89 | 0% | 0% | 0% | 0% | 0% | 0% |
†
Considered HPV52 positive for those samples in which it could not be confirmed or ruled out